Author

Bence Réthi

Karolinska University HospitalORCID 0000-0001-8220-5015Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron R. WinkleriD· 1 shared Alexander EspinosaiD· 1 shared Ana Godec· 1 shared Anatoly P. DubnovitskyiD· 1 shared Bruno RaposoiD· 1 shared Diego Velasquez PulgariniD· 1 shared Fredrik WermelingiD· 1 shared Greta HultqvistiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aaron R. WinklerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJun 30, 2026

A new humanized TCR transgenic mouse model to study citrullinated tenascin C reactive T cells relevant to rheumatoid arthritis

Marlene Schülein, M. Gomes Afonso, Merel Sijbranda…·Bruno Raposo

DOI 10.64898/2026.02.12.705563

mouseflow cytometry

𝕏 PostBluesky

BioengineeringbioRxivPreprintNov 28, 2025

Engineered Fab glycosylation of a blood-brain barrier transporter single-chain variable fragment preserved functionality but did not impact anti-drug antibody formation

Gustaf Hederoth, Jielu Liu, Ana Godec…·Greta Hultqvist

This study engineered sialylation on a scFv-based therapeutic to reduce anti-drug antibodies but found no significant impact on immunogenicity or pharmacokinetics in mice.

DOI 10.1101/2025.11.28.691100

mouseprotein structure

𝕏 PostBluesky